CHRISTOPHER RICHARD bought LEXX
July 29, 2025 · Form 4 insider transaction
CHRISTOPHER RICHARD bought 15,000 shares of Lexaria Bioscience Corp. at $0.91 per share, a transaction worth $13.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$0.91
Total value
$13.6K
InsiderCHRISTOPHER RICHARD
Role—
Securitycommon shares
Transaction codeP: Open-market purchase
Transaction dateJuly 29, 2025
Filing dateJuly 30, 2025
Shares owned after65,000
OwnershipDirect
10b5-1 planNo
AmendedNo